Treatment-related burkitt's lymphoma: Literature review and case report of successful treatment with rituximab monotherapy

Acta Haematologica

Volumn 122, Issue 4, 2009, Pages 211-215

  Nagasaki, Akitoshi ^a   Yamanoha, Atsushi ^a   Okudaira, Taeko ^a   Miyagi, Takashi ^a   Takasu, Nobuyuki ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

Burkitt's lymphoma; Oropharyngeal cancer; Radiotherapy; Rituximab; Second malignant neoplasm

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; RITUXIMAB; VINCRISTINE;

AGED; ANAMNESIS; ARTICLE; BURKITT LYMPHOMA; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CASE REPORT; DRUG TREATMENT FAILURE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; OROPHARYNX CANCER; PRIORITY JOURNAL; RADIATION INJURY; TREATMENT DURATION; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

AGED; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC AGENTS; BURKITT LYMPHOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MANDIBULAR NEOPLASMS; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SECOND PRIMARY; OROPHARYNGEAL NEOPLASMS; REMISSION INDUCTION; TIME FACTORS;

EID: 70350547908     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000253028     Document Type: Article

References (20)

1. Blum KA, Lozanski G, Byrd JC: Adult Burkitt leukaemia and lymphoma. Blood 2004; 104: 3009-3020.
2. Ferry JA: Burkitt's lymphoma: Clinicopathologic features and differential diagnosis. Oncologist 2006; 11: 375-383.
3. Travis LB: The epidemiology of second primary cancers. Cancer Epidemiol Biomarkers Prev 2006; 15: 2020-2026.
4. Krishnan B, Morgan GJ: Non-Hodgkin lymphoma secondary to cancer chemotherapy. Cancer Epidemiol Biomarkers Prev 2007; 16: 377-380.
5. Cheson BD, Leonard JP: Monoclonal antibody therapy for B-cell non-Hodgkin's lymphoma. N Engl J Med 2008; 359: 613-626.
6. Thomas DA, Faderl S, O'Brien S, Bueso-Ramos C, Cortes J, Garcia-Manero G, Giles FJ, Verstovsek S, Wierda WG, Pierce SA, Shan J, Brandt M, Hagemeister FB, Keating MJ, Cabanillas F, Kantarjian H: Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitttype lymphoma or acute lymphoblastic leukemia. Cancer 2006; 106: 1569-1580.
7. Oriol A, Ribera JM, Bergua J, Mesa EG, Grande C, Esteve J, Brunet S, Moreno MJ, Escoda L, Hernandez-Rivas JM, Hoelzer D: High-dose chemotherapy and immunotherapy in adult Burkitt lymphoma: comparison of results in human immunodeficiency virus- infected and noninfected patients. Cancer 2008; 113: 117-125.
8. Di Nicola M, Carlo-Stella C, Mariotti J, Devizzi L, Massimino M, Cabras A, Magni M, Matteucci P, Guidetti A, Gandola L, Gianni AM: High response rate and manageable toxicity with an intensive, short-term chemotherapy programme for Burkitt's lymphoma in adults. Br J Haematol 2004; 126: 815-820.
9. Salloum E, Tallini G, Levy A, Cooper DL: Burkitt's lymphoma-leukemia in patients treated for Hodgkin's disease. Cancer Invest 1996; 14: 527-533.
10. Ikeda T, Sato K, Yamashita T, Kanai Y, Kuwada N, Matsumura T, Nakamura Y, Kimura F, Motoyoshi K: Burkitt's acute lymphoblastic leukaemia transformation after myelodysplastic syndrome. Br J Haematol 2001; 115: 69-71.
11. Miyagi T, Nagasaki A, Nakazato T, Hyakuna N, Takasu N, Masuda M: Emergence of secondary acute lymphoblastic leukemia of Burkitt type after treatment of rhabdomyosarcoma. Med Pediatr Oncol 2003; 41: 471-472.
12. Hongeng S, Parapakpenjun S, Pakakasama S, Rerkamnuaychoke B, Pornkul R: Secondary Burkitt lymphoma in a retinoblastoma patient with 13q deletion syndrome. Pediatr Blood Cancer 2006; 46: 524-526.
13. Raina V, Medhi K, Kumar R, Kadam PA, Kataria S, Chopra A, Kalita D: Burkitt's leukemia after treatment of primary mediastinal nonseminomatous germ cell tumor. J Clin Oncol 2008; 26: 2212-2214.
14. Perkins AS, Friedberg JW: Burkitt lymphoma in adults. Hematology Am Soc Hematol Educ Program 2008; 2008: 341-348.
15. Crosswell HE, Bergsagel DJ, Yost R, Lew G: Successful treatment with modified choprituximab in pediatric aids-related advanced stage Burkitt lymphoma. Pediatr Blood Cancer 2008; 50: 883-885.
16. Bay A, Dogan M, Acikgoz M, Oner AF: Rituximab in a child with relapsed Burkitt lymphoma. Pediatr Blood Cancer 2007; 49: 218.
17. de Vries MJ, Veerman AJ, Zwaan CM: Rituximab in three children with relapsed/refractory B-cell acute lymphoblastic leukaemia/ Burkitt non-Hodgkin's lymphoma. Br J Haematol 2004; 125: 414-415.
18. Yokohama A, Tsukamoto N, Uchiumi H, Handa H, Matsushima T, Karasawa M, Murakami H, Nojima Y: Durable remission induced by rituximab-containing chemotherapy in a patient with primary refractory Burkitt's lymphoma. Ann Hematol 2004; 83: 120-123.
19. Cohen Y, Amir G, Rachmilewitz EA, Polliack A: Sustained complete remission following a combination of very low intensity chemotherapy with rituximab in an elderly patient with Burkitt's lymphoma. Haematologica 2002; 87:ELT04.
20. Koren-Michowitz M, Rahimi-Levene N, Volcheck Y, Hardan I, Kornberg A: Rituximab monotherapy as interim therapy in precursor B-ALL adults during periods of hepatic toxicity: report of two cases. Am J Hematol 2006; 81: 979-980.